Get the Daily Brief
Latest Biotech News
Breakthrough in Brain Science: Adult Neurogenesis Confirmed in Human Hippocampus
Research led by Karolinska Institutet demonstrates ongoing adult neurogenesis in the human hippocampus using advanced single-nucleus RNA sequencing, flow cytometry, and spatial transcriptomics....
AI Leap in Fertility: Columbia’s STAR System Detects Sperm Missed by Human Experts
Columbia University's STAR (Sperm Tracking and Recovery) AI system identified 44 sperm cells in samples previously deemed 'sterile' by manual technicians, leading to a successful pregnancy. This...
University of Copenhagen Secures $109M Grant to Establish Protein Design Center
The Novo Nordisk Foundation awarded $109 million to the University of Copenhagen to launch a Center for Protein Design (CPD) targeting advancement in designed proteins for therapeutic, industrial,...
Health Tech Financing Surges: Digital Startups Raise $6.4 Billion amid AI Boom
Digital health startups in the U.S. attracted $6.4 billion in funding across 245 deals during the first half of 2025, driven by strong investor enthusiasm for AI applications in healthcare. This...
Viome and Microsoft Partner for RNA-Driven Preventive Health
Viome Life Sciences has partnered with Microsoft to integrate AI-powered RNA-based molecular diagnostics into personalized healthcare. This collaboration leverages Viome's gene expression data...
Apogee's IL-13 Antibody Shows Promise for Eczema Treatment
Apogee Therapeutics reported positive Phase 2 trial results for its anti-IL-13 antibody APG777 in atopic dermatitis, achieving a 71% reduction in eczema severity after 16 weeks. The treatment met...
FDA Approvals and Challenges Impacting Biotech Sector
The FDA approved KalVista Pharmaceuticals’ sebetralstat for hereditary angioedema, representing a vital new therapeutic option for rare swelling disorders. Meanwhile, the agency faces deepening...
Cogent Biosciences Advances Mastocytosis Drug Toward FDA Approval
Cogent Biosciences announced that its phase 3 trial for bezuclastinib in indolent systemic mastocytosis met the primary endpoint, positioning the drug for potential FDA approval. The compound...
University of Copenhagen Secures $109M Grant for Protein Design Center
The Novo Nordisk Foundation awarded $109 million to the University of Copenhagen to establish a Center for Protein Design (CPD), aiming to become a European leader in synthetic protein...
AI Breakthrough Finds Viable Sperm in Previously Sterile Samples
Columbia University’s STAR AI system detected 44 sperm cells in male infertility samples previously deemed sterile by manual embryologist review. By adapting astrophysics star-detection...
New Evidence Confirms Adult Human Brain Neurogenesis
Researchers at Karolinska Institutet provided direct evidence of ongoing neurogenesis in the adult human hippocampus, identifying proliferating neural progenitor cells through single-nucleus RNA...
Clinical Innovation Insights: Trial Trailblazers Podcast Series
The 'Trial Trailblazers' podcast offers an inside look at groundbreaking clinical research across diverse therapeutic areas, including rare pediatric diseases, Alzheimer's natural killer cell...
Biotech Growth and Regulatory Issues in Vienna and Europe
Vienna's biotech sector grew to €22.7 billion in 2023, driven by advances in research, innovation, and workforce expansion, positioning the city as a burgeoning life sciences hub. Concurrently,...
AI and Digital Transformation in Rural Healthcare Settings
Microsoft is accelerating digital innovation in rural hospitals by addressing cybersecurity challenges and promoting AI adoption with discounted tools, training, and an innovation lab. The...
Apogee’s Eczema Drug Shows Midstage Success Amid Established Competitors
Apogee Therapeutics has announced promising midstage clinical trial results for APG777, its experimental long-acting antibody therapy targeting atopic dermatitis. The trial demonstrated that...
FDA Faces Talent Drain and Morale Crisis Under Commissioner Makary
The FDA is experiencing a significant loss of experienced personnel amid low morale and heightened political interference. Following a reduction of 19% of its workforce coinciding with the...
US-China Regulatory Tensions Threaten Cross-Border Drug Development
A regulatory chill is emerging as the FDA signals tighter controls on clinical trials that transfer Americans’ cells to China for genetic engineering before reinfusion. Provoked by biosecurity...
Columbia’s AI System Detects Hidden Sperm, Enables Pregnancy Breakthrough
Columbia University’s STAR (Sperm Tracking and Recovery) platform applied astrophysics-derived algorithms to identify sperm cells missed by conventional microscopy in samples deemed sterile....
Novartis’ Cosentyx Falls Short in Giant Cell Arteritis Phase 3 Trial
Novartis announced that its blockbuster drug Cosentyx failed to outperform placebo in a Phase 3 study targeting giant cell arteritis, an autoimmune blood vessel disorder. The antibody therapy was...
European Commission Fines Alchem for Decade-Long API Cartel Participation
The European Commission concluded its investigation into Alchem, fining the drugmaker for involvement in an anti-competitive cartel regarding active pharmaceutical ingredients (APIs) spanning over...